Related Experiment Video
Updated: May 9, 2026
Development of a Quantitative Recombinase Polymerase Amplification Assay with an Internal Positive Control
Published on: March 30, 2015
Cryptosporidium hominis infection diagnosed by real-time PCR-RFLP
Hyeng-Il Cheun1, Kyungjin Kim, Sejoung Yoon
1Department of Malaria and Parasitic Diseases, National Institute of Health, Chungcheongbuk-do 363-951, Korea.
Abstract:
There are approximately 20 known species of the genus Cryptosporidium, and among these, 8 infect immunocompetent or immunocompromised humans. C. hominis and C. parvum most commonly infect humans. Differentiating between them is important for evaluating potential sources of infection. We report here the development of a simple and accurate real-time PCR-based restriction fragment length polymorphism (RFLP) method to distinguish between C. parvum and C. hominis. Using the CP2 gene as the target, we found that both Cryptosporidium species yielded 224 bp products. In the subsequent RFLP method using TaqI, 2 bands (99 and 125 bp) specific to C. hominis were detected. Using this method, we detected C. hominis infection in 1 of 21 patients with diarrhea, suggesting that this method could facilitate the detection of C. hominis infections.
Insights
A new real-time PCR-restriction fragment length polymorphism (RFLP) method accurately distinguishes Cryptosporidium hominis and Cryptosporidium parvum. This technique aids in identifying infection sources and detecting C. hominis in patients with diarrhea.
Area of Science:
- Medical Parasitology
- Molecular Biology
- Infectious Diseases
Background:
- Cryptosporidium is a genus with approximately 20 species, 8 of which infect humans.
- Cryptosporidium hominis and Cryptosporidium parvum are the most common species infecting humans.
- Distinguishing between C. hominis and C. parvum is crucial for identifying infection sources.
Purpose of the Study:
- To develop a simple and accurate method for differentiating C. hominis and C. parvum.
- To utilize real-time PCR-based restriction fragment length polymorphism (RFLP) for species identification.
Main Methods:
- Targeting the CP2 gene for amplification via real-time PCR.
- Employing TaqI restriction enzyme for RFLP analysis.
- Analyzing fragment sizes to differentiate between Cryptosporidium species.
Main Results:
- Both C. hominis and C. parvum produced 224 bp products using the CP2 gene target.
- RFLP analysis with TaqI revealed specific bands (99 and 125 bp) for C. hominis.
- The method successfully identified C. hominis in one of 21 patients presenting with diarrhea.
Conclusions:
- The developed real-time PCR-RFLP method is effective for distinguishing C. hominis and C. parvum.
- This technique can facilitate the diagnosis and source investigation of C. hominis infections.
- The findings contribute to improved management of cryptosporidiosis.
